Chemistory of Fibrates.

Area of Science:

• Biochemistry
• Pharmacology
• Metabolic Diseases

Background:

• Fibrates, developed since 1962, are widely used to treat dyslipidemia.
• They effectively lower plasma triglycerides and cholesterol.
• Multiple biochemical mechanisms contribute to their therapeutic effects.

Purpose of the Study:

• To review the biochemical mechanisms of fibrate action.
• To discuss fibrate targets, pathways, and molecular interactions.
• To highlight aldose reductase as a novel fibrate target.

Main Methods:

• Literature review of fibrate pharmacology and biochemistry.
• Analysis of structure-based inhibitor design studies.
• Discussion of biochemical pathways involved in lipid metabolism and aldose reductase activity.

Main Results:

• Fibrates modulate lipid metabolism via induced lipoprotein lipolysis, altered hepatic fatty acid uptake, enhanced LDL removal, reduced neutral lipid exchange, and increased HDL production.
• Aldose reductase (AR) is identified as an independent target of fibrate activity.
• AR plays a role in glucose metabolism and diabetic complications.

Conclusions:

• Fibrates exert their lipid-lowering effects through diverse biochemical mechanisms.
• The identification of aldose reductase as a fibrate target offers new insights into potential therapeutic applications beyond dyslipidemia.
• Understanding these pathways is crucial for developing novel treatments for metabolic disorders.